Can I Start Wegovy at 0.5 mg? Understanding the Dosing Guidelines for Weight Loss

Last reviewed: July 3, 2026

Last updated: July 3, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Starting a GLP-1 medication like semaglutide involves careful dose planning to balance effectiveness with tolerability. The standard entry point of 0.5 mg weekly is designed to help your system adjust gradually while building toward your optimal therapeutic dose. PlexusDx works with patients across all 50 states to create personalized semaglutide protocols that align with your health goals and metabolic profile.

Why 0.5 mg Is the Standard Starting Dose for Semaglutide

The 0.5 mg weekly dose represents the lowest effective concentration in most GLP-1 weight loss protocols. This entry-level dose allows your gastrointestinal system to acclimate to semaglutide's appetite-suppressing effects without overwhelming your body. Research on semaglutide therapy shows that beginning at this dose reduces nausea, vomiting, and digestive discomfort compared to higher starting points, making treatment more tolerable during the critical first weeks.

Your body's GLP-1 receptors—the molecular targets that semaglutide activates—respond gradually to therapy. Starting at 0.5 mg gives these receptors time to upregulate and establish new signaling patterns without triggering excessive satiety or side effects. PlexusDx providers monitor your individual response during this phase to ensure you're progressing safely toward your personalized dose target.

The Typical Semaglutide Titration Schedule and Timeline

Most patients remain on the 0.5 mg dose for four weeks before advancing to the next level. This one-month window allows your appetite-control hormones to stabilize and your digestive system to adapt. After four weeks, the typical next step is 1.0 mg weekly, followed by increases to 1.7 mg and potentially 2.4 mg—depending on your weight loss progress, side effect tolerance, and clinical goals.

The pace of titration is not fixed; it depends entirely on how your individual body responds. Some patients benefit from staying at 0.5 mg for six to eight weeks, while others progress faster. PlexusDx compounded semaglutide allows for flexible dosing schedules that match your unique metabolic needs, ensuring you reach an effective dose without unnecessary discomfort. Your dose may need to go up. Your price won't—PlexusDx charges a flat monthly rate regardless of which dose level you're using.

How Genetic Testing Helps Personalize Your Starting Dose

Your genetic blueprint influences how efficiently your body processes semaglutide and responds to GLP-1 activation. The PlexusDx Precision Peptide Genetic Test examines key variants in genes like GLP1R (rs6923761) and GIPR (rs1800437) that directly control GLP-1 receptor sensitivity and signaling strength. Patients with specific genetic profiles may achieve stronger weight loss responses at lower doses, while others benefit from faster titration schedules.

This genetic insight transforms the standard 0.5 mg starting point from a one-size-fits-all approach into a personalized foundation tailored to your peptide pathways. The test maps 14 distinct pathways and 150+ genetic insights related to appetite regulation, metabolism, and drug response. For $99 as an add-on after your first month of treatment, PlexusDx patients gain clarity on whether their body is primed for semaglutide success at the entry dose or whether a modified approach would be more effective.

Common Side Effects at 0.5 mg and How to Manage Them

Nausea remains the most frequently reported side effect during the first two weeks of semaglutide therapy, even at the modest 0.5 mg dose. Most patients find this sensation mild and manageable at the starting point, unlike higher doses where gastrointestinal effects can be more pronounced. Eating smaller, slower meals and avoiding greasy or high-fat foods helps reduce nausea severity, as does staying well hydrated throughout the day.

Other early-stage effects include mild appetite suppression, constipation, or slight fatigue as your metabolism adjusts. These responses are generally signs that the medication is working—your body is responding to reduced caloric intake and the hormonal changes semaglutide triggers. If side effects become bothersome, your PlexusDx provider can adjust your meal timing, suggest symptom-management strategies, or slow your titration schedule to ease the transition. The goal is consistent, sustainable progress toward your weight loss target.

When to Advance Beyond 0.5 mg and Signs You're Ready

After four weeks on 0.5 mg, you should evaluate whether weight loss is occurring and side effects are manageable. Most patients see meaningful results—typically one to three pounds weekly—within the first month, signaling that the medication is active in your system. If you're tolerating the dose well and your appetite has noticeably decreased, moving to 1.0 mg in week five is usually appropriate and safe.

However, readiness for dose escalation is individual. If you're experiencing persistent nausea, significant bloating, or other discomfort, staying at 0.5 mg for an additional two to four weeks may be smarter than advancing immediately. PlexusDx providers work with you to find the sweet spot—high enough to drive weight loss, low enough to keep side effects minimal. The emphasis is on steady, personalized progress rather than rushing through a standardized protocol.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Is 0.5 mg the only way to start semaglutide, or can I begin at a higher dose?

While 0.5 mg is the evidence-based standard starting dose, some patients with prior GLP-1 exposure or specific health profiles may tolerate higher entry doses. PlexusDx providers evaluate your medical history, current medications, and tolerance profile to confirm whether 0.5 mg is optimal for you or if a modified approach is warranted. Starting too high increases side effect risk without necessarily improving outcomes.

How long does it take to see weight loss results at 0.5 mg?

Most patients notice appetite suppression within three to five days of the first 0.5 mg injection, though measurable weight loss typically emerges within one to two weeks. Clinical trials show an average loss of one to three pounds per week during the initial titration phase. Results vary based on your starting weight, diet adherence, exercise level, and individual metabolic rate.

Can I get compounded semaglutide starting at 0.5 mg through PlexusDx?

Yes. PlexusDx provides compounded semaglutide injections from licensed 503A compounding pharmacies starting at $149 monthly, with no flat per-compound pricing tiers. Whether you're on 0.5 mg or 2.4 mg, your monthly cost remains flat, and PlexusDx serves all 50 states without requiring insurance or membership fees.

What if I experience strong nausea at 0.5 mg—should I stop the medication?

Mild nausea is expected and typically resolves within one to two weeks as your body acclimates. However, severe or persistent nausea is uncommon at 0.5 mg and should be discussed with your PlexusDx provider immediately. They may adjust meal timing, recommend anti-nausea strategies, or modify your titration pace rather than discontinuing treatment entirely.

How does the PlexusDx Precision Peptide Genetic Test affect my 0.5 mg starting dose?

The test reveals genetic variants in GLP1R, GIPR, FTO, and MC4R that influence your receptor sensitivity and weight loss potential. Results may suggest that you'll respond optimally to standard 0.5 mg titration, or they may indicate genetic advantages that could accelerate your progress or reduce side effects at your current dose. At $99 after your first treatment month, the test personalizes your entire semaglutide journey.

Related Reading

• Wegovy For Weight Loss 2
• Wegovy Weight Loss Pills
• Wegovy 025 Mg 05 Ml Pen
• Wegovy Vs Zepbound Weight Loss

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.